3 Biotech is a prestigious interdisciplinary journal, published by SPRINGER HEIDELBERG, focusing on the evolving fields of biotechnology, agricultural and biological sciences, and environmental science. With an impressive impact factor and categorized in Q2 across multiple fields in the 2023 rankings, this journal stands out for its contribution to innovative research and its commitment to advancing scientific understanding. Featuring rigorous peer-reviewed articles, it serves as a vital resource for researchers, professionals, and students alike, further enhanced by its significant presence in Scopus rankings. This journal facilitates open discussions and collaborative efforts, aiming to bridge the gap between theoretical research and practical applications in biotechnology. As it continues to publish impactful studies from 2011 to 2024, 3 Biotech is dedicated to shaping the future of biosciences and fostering meaningful scientific advancements.

JOURNAL OF BIOTECHNOLOGY, published by Elsevier, stands as a premier platform in the fields of Applied Microbiology, Biotechnology, Bioengineering, and Medicine. With an ISSN of 0168-1656 and an E-ISSN of 1873-4863, this journal has significantly contributed to the advancement of biotechnological research since its inception in 1984 and continues to be a vital resource until 2024. Notably ranked in the Q2 quartile across multiple categories, it excels with impressive Scopus rankings, placing within the top 20% in Applied Microbiology and Biotechnology. This underscores its impact on both the scientific community and the ongoing developments in biotechnological applications. The journal encourages submissions that promote innovative research and practical insights, fostering collaboration among researchers, professionals, and students alike. Although it does not currently offer Open Access options, the journal remains highly regarded for its rigorous peer-review process and commitment to excellence in biotechnological literature.

The Electronic Journal of Biotechnology is a premier Open Access journal published by Pontificia Universidad Catolica de Valparaiso, Chile, dedicated to advancing the fields of applied microbiology and biotechnology. With its inception in 1998 and an unwavering commitment to sharing knowledge, the journal has garnered a respectable ranking within the Q3 quartile for both its biotechnology and applied microbiology categories as of 2023, reflecting its significance in the academic community. Researchers and professionals will find its editorial rigor complemented by a robust platform for disseminating innovative findings, fostering collaboration, and driving forward biotechnology discussions. Given its inclusive approach, having transitioned to Open Access in 2014, the journal ensures that research is accessible to a global audience, making it a valuable resource for students, academics, and industry practitioners alike. Through the publication of original research, reviews, and critical insights, the Electronic Journal of Biotechnology aims to bridge the gap between scientific discovery and practical application, ultimately contributing to advancements in health, agriculture, and environmental sustainability.

BIOTECHNOLOGY AND BIOPROCESS ENGINEERING, published by the Korean Society for Biotechnology and Bioengineering, is a prominent journal in the fields of applied microbiology, biotechnology, bioengineering, and biomedical engineering. Since its inception in 1996, this journal has served as a vital platform for researchers and professionals, facilitating the dissemination of cutting-edge research and innovative applications related to bioprocesses and biotechnology systems. With an ISSN of 1226-8372, this journal is ranked within the Q3 quartile across several categories, demonstrating its relevance and impact in the academic community. Although it operates under traditional access modalities, the journal strives to provide quality and timely insights into the advancements in bioprocess technology and microbial applications, fostering a collaborative environment for knowledge exchange. Notably, it is indexed with a respectable presence on Scopus, making it a valuable resource for students and professionals seeking the latest developments in biotechnology. For more details, kindly refer to the Korean Science Technology Center, #704 Yeoksam-Dong, Gangnam-Ku, Seoul 135-703, South Korea.

EuroBiotech Journal, published by SCIENDO, is an essential open-access platform for researchers and professionals in the fields of biomedical engineering, biotechnology, food science, genetics, molecular biology, and molecular medicine. Since its establishment in 2017, the journal has aimed to disseminate high-quality, peer-reviewed research that fosters innovation and collaboration within the European biotechnological landscape and beyond. With its target audience comprising academic scholars, industry practitioners, and students, EuroBiotech Journal has successfully carved a niche, achieving notable Scopus ranks and quartiles, such as Q3 in Biotechnology and Food Science. Based in Warsaw, Poland, the journal welcomes manuscripts that contribute to the vast array of current topics, addressing pressing challenges and discovering solutions pertinent to biotechnology and its applications. As you explore the latest advancements published in this journal, you will find a rich source of knowledge that promotes a deeper understanding of the dynamic and evolving field of biotechnological research.

ENGINEERING IN LIFE SCIENCES, published by Wiley, is a pivotal journal for professionals, researchers, and students dedicated to advancing the interdisciplinary fields of bioengineering, biotechnology, and environmental engineering. With an ISSN of 1618-0240 and an E-ISSN of 1618-2863, this journal has established itself as a reputable platform for disseminating innovative research findings and breakthroughs in engineering applications within the life sciences. Currently holding a prestigious Q2 ranking in multiple categories, including bioengineering and environmental engineering, it reflects a strong commitment to high-quality, impactful research (Scopus ranks: Environmental Science - Rank #61/197, Biochemistry, Genetics and Molecular Biology - Rank #112/311). The journal spans contributions from 2004 to 2024, ensuring a comprehensive archiving of evolving scientific discourse. Although it does not currently offer open access, its curated articles are accessible through institutional and single-article purchases, providing valuable insights and updates for the academic community. Join us in shaping the future of engineering within life sciences and stay informed on critical advancements that are driving innovation across multiple disciplines.

Biotechnology and Genetic Engineering Reviews is a prominent journal published by Taylor & Francis Ltd, specializing in the rapidly evolving fields of biotechnology and genetic engineering. Since its inception in 1984, this journal has served as a critical platform for researchers and professionals to disseminate groundbreaking scientific findings, review methodologies, and discuss emerging trends within the domain. With a substantial track record of convergence in its publication history from various years, it currently holds Q2 rankings in both Bioengineering and Biotechnology, alongside a Q3 ranking in Molecular Biology for 2023. Its dedication to quality research is reflected in its Scopus rankings, which position the journal favorably within the competitive landscape of biochemistry and molecular biology. Although it is not an open-access journal, Biotechnology and Genetic Engineering Reviews remains committed to providing accessible insights to the global scientific community, making it an invaluable resource for students, academics, and industry professionals keen on advancing their knowledge in these crucial fields.

Journal of Biological Engineering, published by BMC, stands as a prominent Open Access journal since 2007, dedicated to advancing the interdisciplinary field of biological engineering. With an ISSN of 1754-1611, this UK-based journal aims to provide a platform for researchers and professionals to disseminate innovative and impactful research across various domains including Biomedical Engineering, Environmental Engineering, Cell Biology, and Molecular Biology. The journal's notable rankings in the 2023 category quartiles exemplify its position within the scientific community, featuring Q2 status in Biomedical Engineering and Environmental Engineering, along with Q3 in Cell Biology and Q2 in Molecular Biology. By maintaining robust Scopus rankings and ensuring free access to cutting-edge research, the Journal of Biological Engineering plays a crucial role in driving discovery and collaboration among scholars, thereby enriching both the academic landscape and applied sciences.

BIOTECHNOLOGY LETTERS is a prestigious peer-reviewed journal that has been at the forefront of biotechnology research since its inception in 1979. Published by Springer, this esteemed journal serves as a vital platform for disseminating cutting-edge research in the fields of applied microbiology, bioengineering, and biotechnology, with a focus on innovative methodologies and technologies. With an impact factor reflecting its critical contribution to the discipline, BIOTECHNOLOGY LETTERS resides in the Q2 and Q3 tiers of various scientific categories, placing it among the notable journals in the biotechnological landscape. Although it offers traditional access options and does not feature open access, the journal embraces a global readership, encouraging submissions from researchers, professionals, and students eager to explore the dynamic advancements in biotechnology. Situated in the Netherlands, it continues to shape the future of the field through relevant, impactful research that addresses contemporary challenges and opportunities in medicine and beyond.

BioTech is a forward-thinking academic journal published by MDPI, specializing in the dynamic fields of applied microbiology, biotechnology, biochemistry, bioengineering, and biomedical engineering. Established for promoting impactful research from 2021 to 2024, this journal aims to bridge the gap between laboratory findings and practical applications, serving as a vital resource for researchers, practitioners, and students alike. With its Open Access model, BioTech ensures that groundbreaking innovations are freely available to the global community, fostering collaboration and knowledge transfer across disciplines. In the 2023 rankings, BioTech holds a strong position in Q2 and Q3 quartiles across various categories, reflecting its commitment to high-quality research output. Being indexed in renowned databases, the journal enhances its visibility and reach, making it a preferred platform for sharing transformative ideas and discoveries in biotechnology and related domains. Set against the backdrop of Switzerland’s thriving research environment, BioTech is poised to become an essential resource in the rapidly evolving landscape of life sciences.